Immune thrombocytopenia in pregnancy – a literature review

V. Drăgoi, I.A. Horhoianu, G. Peltecu, A.M. Panaitescu

Rezumat: Thrombocytopenia (a platelet value of less than 150x109/L) is a very important hematologic disorder in pregnancy and is encountered in 7-10% of the pregnant women population. There are multiple causes of thrombocytopenia, related or not to pregnancy. The focus of this paper is immune thrombocytopenia (ITP) in pregnancy, and we review the pathological mechanisms, the diagnostic methods, the management, the treatment options and neonatal outcome by analysing and discussing the most recent literature data. It is mandatory to accurately diagnose, manage and treat hematologic pathologies during pregnancy. Immune thrombocytopenia in pregnancy may be an apparently limited disorder, but it has often proven to be a challenge for obstetricians, hematologists and neonatologists, who need to work together and supervise these cases in order to prevent complications and ensure the best outcome available for both mother and newborn.
Cuvinte cheie: immune thrombocytopenia, platelet value, neonatal.